Whiting, D, Cowen, PJ. Drug information update: agomelatine. Psychiatrist
2013; 37: 356–8.
Koesters, M, Guaiana, G, Cipriani, A, Becker, T, Barbui, C.
Agomelatine efficacy and acceptability revisited: systematic review and meta-analysis of published and unpublished randomised trials. Br J Psychiatry
2013; 203: 179–87.
National Institute for Health and Clinical Excellence. Agomelatine for the Treatment of Major Depressive Episodes (Terminated Appraisal) (Technology Appraisal TA231). NICE, 2011.
Eyding, D, Lelgemann, M, Grouven, U, Hrter, M, Kromp, M, Kaiser, T, et al Reboxetine for acute treatment of major depression: systematic review and meta-analysis of published and unpublished placebo and selective serotonin reuptake inhibitor controlled trials. BMJ
2010; 341: c4737.